Literature DB >> 1740699

Quantitating tumor glucose metabolism with FDG and PET.

R A Hawkins, Y Choi, S C Huang, C Messa, C K Hoh, M E Phelps.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1740699

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  17 in total

1.  An evaluation of 2-deoxy-2-[18F]fluoro-D-glucose and 3'-deoxy-3'-[18F]-fluorothymidine uptake in human tumor xenograft models.

Authors:  Heather Keen; Bernd Pichler; Damaris Kukuk; Olivier Duchamp; Olivier Raguin; Aoife Shannon; Nichola Whalley; Vivien Jacobs; Juliana Bales; Neill Gingles; Sally-Ann Ricketts; Stephen R Wedge
Journal:  Mol Imaging Biol       Date:  2012-06       Impact factor: 3.488

2.  A synthetic lethal drug combination mimics glucose deprivation-induced cancer cell death in the presence of glucose.

Authors:  James H Joly; Alireza Delfarah; Philip S Phung; Sydney Parrish; Nicholas A Graham
Journal:  J Biol Chem       Date:  2019-12-30       Impact factor: 5.157

3.  Metabolism of [U-13 C]glucose in human brain tumors in vivo.

Authors:  Elizabeth A Maher; Isaac Marin-Valencia; Robert M Bachoo; Tomoyuki Mashimo; Jack Raisanen; Kimmo J Hatanpaa; Ashish Jindal; F Mark Jeffrey; Changho Choi; Christopher Madden; Dana Mathews; Juan M Pascual; Bruce E Mickey; Craig R Malloy; Ralph J DeBerardinis
Journal:  NMR Biomed       Date:  2012-03-15       Impact factor: 4.044

4.  Mean and maximum standardized uptake values in [18F]FDG-PET for assessment of histopathological response in oesophageal squamous cell carcinoma or adenocarcinoma after radiochemotherapy.

Authors:  Matthias Schmidt; Elfriede Bollschweiler; Markus Dietlein; Stefan P Mönig; Carsten Kobe; Daniel Vallböhmer; Daniel Vallboehmer; Wolfgang Eschner; Arnulf Hölscher; Harald Schicha
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-12-19       Impact factor: 9.236

5.  Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of thymoma: a preliminary report.

Authors:  R S Liu; S H Yeh; M H Huang; L S Wang; L S Chu; C P Chang; Y K Chu; L C Wu
Journal:  Eur J Nucl Med       Date:  1995-12

6.  Positron emission tomography and breast masses: comparison with clinical, mammographic, and pathological findings.

Authors:  J P Crowe; L P Adler; R R Shenk; J Sunshine
Journal:  Ann Surg Oncol       Date:  1994-03       Impact factor: 5.344

7.  Generalized whole-body Patlak parametric imaging for enhanced quantification in clinical PET.

Authors:  Nicolas A Karakatsanis; Yun Zhou; Martin A Lodge; Michael E Casey; Richard L Wahl; Habib Zaidi; Arman Rahmim
Journal:  Phys Med Biol       Date:  2015-10-28       Impact factor: 3.609

8.  Whole-body direct 4D parametric PET imaging employing nested generalized Patlak expectation-maximization reconstruction.

Authors:  Nicolas A Karakatsanis; Michael E Casey; Martin A Lodge; Arman Rahmim; Habib Zaidi
Journal:  Phys Med Biol       Date:  2016-07-06       Impact factor: 3.609

9.  Comparison between 68Ga-bombesin (68Ga-BZH3) and the cRGD tetramer 68Ga-RGD4 studies in an experimental nude rat model with a neuroendocrine pancreatic tumor cell line.

Authors:  Caixia Cheng; Leyun Pan; Antonia Dimitrakopoulou-Strauss; Martin Schäfer; Carmen Wängler; Björn Wängler; Uwe Haberkorn; Ludwig G Strauss
Journal:  EJNMMI Res       Date:  2011-12-13       Impact factor: 3.138

10.  Quantitation of glucose uptake in tumors by dynamic FDG-PET has less glucose bias and lower variability when adjusted for partial saturation of glucose transport.

Authors:  Simon-Peter Williams; Judith E Flores-Mercado; Ruediger E Port; Thomas Bengtsson
Journal:  EJNMMI Res       Date:  2012-02-01       Impact factor: 3.138
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.